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Objectives: The objective of this study is to identify what information is considered useful by 
primary care providers (PCPs) and what communication methods are preferred when information 
is shared by community pharmacists. Methods: A mixed methods approach was used to collect 
data from PCPs interacting with North Carolina community pharmacies participating in a prior 
study. In that study, community pharmacists shared 873 medication therapy problems (MTPs) 
with PCPs by fax. PCP responses were collected to identify whether the MTP information shared 
was considered “useful.” A cohort of 173 PCPs found the information “useful” and were 
recruited for participation in semi-structured interviews. The quantitative data were analyzed 
using chi-square and the qualitative interviews were analyzed using MAXQDA coding software. 
Results: A total of 873 MTPs were communicated to PCPs and 26% (n=230) were deemed to be 
useful by PCPs. Of the MTPs that were identified and deemed to be useful by PCPs, 37% (n=86) 
were accompanied with recommendations while 63% (n=144) were not (P=0.0316). Two PCPs 
completed interviews. PCPs value information about insurance coverage and medication cost; 
they prefer sharing information via electronic methods or fax. Variation exists among PCPs in 
their desire to build relationships with pharmacists. PCPs do not always consider community 
pharmacists as members of the interdisciplinary team but do believe successful communication 
must occur before a working relationship can be established. Conclusion: Community 
pharmacists should take into consideration specific PCP preference of communication methods 
and usefulness of information shared when establishing a collaborative relationship with PCPs. 
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Interdisciplinary care is defined as a process in which healthcare professionals from 
different fields of study work together to share their expertise and skill to impact patient care 
outcomes.1 This type of collaboration has been shown to improve health outcomes and reduce 
costs. Interdisciplinary care led to a reduction of 30-day hospital readmission rates in patients 
with high-risk medical conditions, and in another example led to a positive economic impact in 
an outpatient pain clinic, saving the hospital and insurance companies $36,228 and $11,482 per 
patient per year, respectively.2-3 While there are successful examples of interdisciplinary care in 
both the inpatient and outpatient setting, a variety of existing barriers limit the scope of 
outpatient interdisciplinary care between pharmacists and primary care providers (PCPs). 
Examples of these barriers include lack of communication, lack of information sharing between 
healthcare providers, and differing opinions of what interdisciplinary care means.4-5 Due to these 
barriers, identification of collaborative opportunities and effective communication strategies for 
outpatient care are needed.  
The driving force behind interdisciplinary care in the outpatient setting includes an 
increase in the number of complex patient cases and a surge in healthcare costs over the last 20 
years, with approximately 90% of older adults in the United States taking ≥ one prescription 
medication in the past month and 40% taking ≥ five medications per month.6 In order to combat 
increasing costs and poor patient outcomes, health plans are moving away from a volume-driven, 
fee-for-service payment structure towards value-driven, pay-for-performance models.6 The shift 
in payment structure has afforded opportunities for pharmacists to provide a variety of 
medication management services. In addition, PCPs are encouraged to integrate pharmacists into 
their patient care team, regardless of proximity of practice, to reduce costs and improve patient 
outcomes. As pharmacists join these teams, however, best practices for communication between 
members of the interdisciplinary team have not yet been established. 
Several collaboration models have been developed to better understand prescriber-
community pharmacist communication.7 Trust, interdependence, role definition, and high-quality 
communication are described as drivers of the collaboration between PCPs and pharmacists by 
all four models of collaboration. 7-11  
In addition to identifying best practices for communication between pharmacists and 
PCPs, it is also important to identify what type of information should be shared between 
settings.12 There is very little literature on what information shared by pharmacists is considered 
valuable to PCPs. A qualitative study in New Zealand examined general practitioners’ perception 
of new clinical services provided by pharmacists and concluded that in order to continue these 
new services, effective communication must be increased for services to be integrated into 
medical practices.13 It was suggested that general practitioners’ acceptance of pharmacist-led 
clinical services are correlated to the general practitioners’ understanding of the 
recommendations communicated by pharmacists.13 Low-quality communication can negatively 
influence the collaborative relationship between these professionals.13 The results of the New 
Zealand study suggest a need for more in-depth evaluation on what type of information is 
considered valuable by PCPs.  
OBJECTIVES 
The objective of this study is to identify (1) what information is considered useful by 
primary care providers (PCPs) and (2) what communication methods are preferred when 
information is shared by community pharmacists.  
 
METHODS 
Study Design & Setting 
A mixed methods approach was used to collect data from PCPs interacting with North 
Carolina community pharmacists. In a previous study, community pharmacists assessed older 
adults for presence of fall-related risk factors, conducted medication reviews to identify 
potentially inappropriate use of medications linked to falls, and shared medication therapy 
problems (MTPs) and recommendations with PCPs.14,15 Information was shared with PCPs by 
fax using a form that included space for the pharmacists to both describe the MTP, as well as 
space to make a recommendation. PCPs were asked to respond to these communications using an 
included prescriber response form. The quantitative portion of this study focused on prescriber-
reported usefulness when a MTP was identified and accompanied by a recommendation. It was 
hypothesized that MTPs where any type of recommendation was made were more likely to be 
useful to PCPs compared to MTPs where a recommendation was not made. The qualitative 
portion of this study focused on communication between PCPs and pharmacists. Semi-structured 
interviews were conducted with PCPs who responded that MTP communications were useful. 
These PCPs were recruited via fax. 
Participants 
Participants of the quantitative portion of the study included PCPs for whom a single 
MTP had been identified and shared with a PCP. For the qualitative portion of the study, 
participants for the semi-structured interviews were PCPs who received MTP communications 
from pharmacists and responded that the information shared was “useful.” PCPs were recruited 
for interviews by fax.  
 
Data Collection 
Quantitative data were collected and coded in the prior study. Medication 
recommendations made by community pharmacists were coded as no recommendation made, 
incomplete recommendation made, and complete recommendation made. PCP responses to MTP 
usefulness were coded as not useful, useful, unsure of usefulness, and no response to usefulness. 
These data were used to test our hypothesis.  
Qualitative interviews were conducted by phone, using a semi-structured interview guide. 
The guide was developed with assistance from the UNC Odum Institute for Research in Social 
Science (https://odum.unc.edu/). The guide was developed around two common themes extracted 
from the four collaboration models. Communication directionality and reciprocity are identified 
as important factors in achieving successful interdisciplinary practice.7 These two themes were 
used to guide the development of questions regarding information sharing and relationships 
between PCPs and pharmacists. 
Data Analysis 
The quantitative data were analyzed using a chi-square test. For qualitative interviews, a 
codebook was developed, and  data were coded and analyzed using MAXQDA software.16 
IRB & Protection of Human Subjects   
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A total of 2020 medication therapy problems (MTPs) were communicated to PCPs. Of 
these, 873 MTPs met inclusion criteria and were included for analysis in the quantitative portion 
of the study. For the qualitative portion of the study, 385 MTPs met inclusion criteria for 
qualitative analysis, and 173 unique PCPs were identified for participation in the semi-structured 
interviews. Two PCPs participated in the qualitative portion of the study and completed 
interviews, with an average length of 22 minutes. Figure 1 represents the breakdown of 
participants. 
Quantitative Results 
Of the 873 MTPs included in the study, 26% (n=230) MTPs were indicated by PCPs as 
“Useful.” Of the MTPs that were identified as “useful” by PCPs, 37% (n=86) were accompanied 
with recommendations while 63% (n=144) were not accompanied with recommendations (Chi-
square = 4.6208, P=0.0316).  
Qualitative Results 
Communication Directionality. PCPs value information from community pharmacists 
regarding insurance coverage and medication costs. In addition, PCPs do not share various 
patient information with pharmacists because they are unaware that pharmacists do not have 
universal electronic health record (EHR) access. One prescriber said, “I was under the 
impression that community pharmacists had [access to] patient demographics when I sent a 
prescription. I did not realize they did not have that.” Communication methods currently utilized 
by PCPs to communicate with pharmacists include phone and fax. PCPs state that fax is the 
easiest method of communication, but electronic methods are preferred over other methods. 
Communication Reciprocity. Variation exists among PCPs in their desire to build 
relationships with pharmacists. Factors that influence PCP willingness to collaborate with 
pharmacists include patient socioeconomic status, geographic locations, and drug complexity. 
Another prescriber stated that healthcare professionals are “trying to save money for the patient 
and provide better health care.” PCPs prefer working with local, community-minded pharmacists 
and believe that successful communication must occur before a working relationship can be 
established between the two professionals. Specifically, one prescriber said, “I think it’s the 
communication first. If you take the time to call somebody, it’s amazing how helpful pharmacists 
want to be and how helpful they are.”  
DISCUSSION 
Although there are an increasing number of pharmacists collaborating with or wishing to 
collaborate with PCPs, the best method and information for pharmacists to communicate with 
PCPs is still unknown.17 This study offers to fill a gap in knowledge and practice of 
interdisciplinary work between pharmacists and PCPs. It used the overarching themes of 
communication directionality and communication reciprocity from the four existing models of 
collaboration to determine what communication methods PCPs prefer and what information 
PCPs find useful when communicating with pharmacists. The results identified can help 
pharmacists overcome common communication barriers between practice settings.  
Communication between pharmacists and PCPs is complex due to a lack of proximity of 
practice and the fact that community pharmacists are not generally co-located in the same facility 
as PCPs. The results of this study emphasize communication, information, and relationship gaps 
that currently exist. For example, pharmacists typically have limited access to crucial patient 
information such as lab results, medical diagnoses, and social history that can impact the level of 
care that patients receive in the community setting.12 In this study, PCPs were unaware that 
pharmacists lack access to this information. This may explain why some PCPs do not proactively 
share patient information with pharmacists, thereby limiting pharmacists’ abilities to make 
informed patient care assessments. The findings suggest that pharmacists wishing to establish a 
collaborative relationship with PCPs should communicate this limitation and request access to 
and sharing of any essential patient information in order to overcome this barrier. Several studies 
reveal successful collaboration strategies among community pharmacists and physicians.19-23 
Another way community pharmacists can overcome the challenge of limited communication is to 
establish EHR access. For example, one community pharmacy was able to work with a local 
PCP to gain access to information and establish read-only EHR access for the community 
pharmacy at no extra cost.18 By implementing this communication strategy, both pharmacists and 
PCPs were able to share information that the other provider may not initially have access to.24 
The implementation of a communication strategy that works best for both the pharmacy and PCP 
workflow will create mutual awareness and respect between the two professionals and allow 
access to currently-limited patient information in order for both professionals to provide better 
care to patients.4 
PCPs may also benefit from access to information only available from within the 
pharmacy. A challenge, however, is identifying what information is most useful to share with 
PCPs. Though a New Zealand study suggested that pharmacists should conduct medication 
reviews and communicate their findings to PCPs, 13 Pharmacists may find that this information 
alone is not always useful for PCPs. The findings of our study suggest that in addition to sharing 
medication therapy problems, pharmacists should include a solution for any problems identified. 
However, simply sharing a solution or recommendation may not be sufficient. The quality of 
pharmacists’ communication impacts prescriber acceptance and response.13 One way to ensure 
that recommendations are of appropriate quality is to use a standardized framework such as the 
Situation, Background, Assessment, and Recommendation (SBAR) method.25-26 This 
communication method has been shown to enhance communication quality and patient safety 
outcomes in interdisciplinary healthcare settings. One study found that by standardizing 
communication methods across all departments using SBAR, phone and in-person 
communication between healthcare professionals had greatly improved and significant 
improvement can be made in the satisfaction and collaboration of healthcare professionals.25 
Pharmacists have the opportunity to share solutions to MTPs in addition to other information that 
may be useful to PCPs, and not otherwise accessible to them, are suggestions for cost-effective 
drug treatments and patient third party formulary information. By ensuring that communications 
to PCPs are clear, concise, and complete, pharmacists contribute a valuable role as part of the 
interdisciplinary care team.   
Another communication challenge addressed by this study is the identification of 
preferred methods for communication between pharmacists and PCPs. Previous studies have 
reported that telephonic communication is the most common method used between PCPs and 
pharmacists.17 However, this study showed that PCPs preferred electronic communication, 
including email or EHR messaging. If electronic communication was unavailable, fax was 
preferred. This is likely because it allows PCPs to review and respond to messages within their 
own workflow. These preferences may vary by PCP, and pharmacists should determine what 
methods are preferred by individual practices when establishing a collaborative relationship.  
Finally, it is evidenced through existing literature and the results of this study that PCPs 
do not always consider pharmacists as a member of the interdisciplinary care team.4-5 
Pharmacists should initiate communication and determine best communication practices with 
PCPs when seeking to establish a collaborative relationship with PCPs. Through this initiation, 
PCPs will be able to acknowledge pharmacists willingness and desire to work with their office 
and build off their communication to create a lasting interdisciplinary healthcare team. 
A limitation of this study includes the small sample size of PCPs interviewed for the 
qualitative arm. This may lead to a decreased generalizability of the qualitative results as they do 
not necessarily represent the perspectives of PCPs as a whole. Another limitation to this study 
was that the forms used by PCPs to respond to MTP communications was not developed to 
appropriately capture prescriber usefulness for communications with multiple MTPs. The forms 
used allowed pharmacists to make multiple recommendations. However, it limited the PCPs to 
provide only one response in the usefulness of these recommendations, not allowing PCPs to 
differentiate usefulness between multiple recommendations. This may limit the validity of the 
study results as PCP responses may not truly reflect the usefulness of the MTP communication. 
Finally, MTPs with no response were included for analysis as a “Not Useful” response. While 
lack of response does not necessarily mean that the PCP did not find the information useful, we 
hypothesize that lack of communication may indicate a lack of usefulness for the PCP. Further 
research is needed to validate this hypothesis.  
CONCLUSION 
Improving communication practices needs to be addressed in order for successful 
interdisciplinary collaboration between PCPs and community pharmacists to exist. Pharmacists 
should consider specific PCP preference of communication methods and usefulness of 
information shared with PCPs when establishing a collaborative relationship with PCPs.  
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Semi-Structured Interview Guide 
Icebreaker 
1. Can you tell me about a specific time when you spoke with a community pharmacist 
other than for new prescriptions or refills? 
Process – Directionality 
2. What kind of information do community pharmacists typically share with you?  
a.  [PROBE: if Q2 not answered directly] What patient information do community 
pharmacists share with you?  
b.  [PROBE] What information do you think pharmacists have that would be of 
value to you? 
3. What kind of information do you typically share with community pharmacists? 
a. [PROBE: If Q3 not answered directly] What patient information do you share 
with community pharmacists?  
b.  [PROBE] What information do you have that would be valuable to community 
pharmacists? 
4. When your practice receives patient care information from community pharmacists, what 
happens to that information? 
a.  [PROBE] How do you like to receive this information? 
b.  [PROBE] Who in your office is responsible for documenting information 
received from community pharmacists? 
c.  [PROBE] What happens next? 
d.  [PROBE] What are the support staff involved with when sharing information 
with community pharmacists? 
e.  [PROBE] What, if anything, would you like to be different? 
5. Walk me through how information is shared from your office to community pharmacists? 
a.  [PROBE] How do you go about sharing information with community 
pharmacists? 
b.  [PROBE] What, if anything, would you like to be different? 
6. Is there something about sharing information that you’d like to talk about that I haven’t 
asked? 
Relationships - Reciprocity 
7. Do you have a relationship with a community pharmacist that goes beyond sending 
prescriptions? 
a. Yes Æ [PROBE] Tell me more about that? 
b. No Æ [PROBE] What, if anything, would you like to change about your 
interaction with them? 
8. How do you feel about your [If no to Q7: lack of] relationship with community 
pharmacists? 
a. [PROBE] How important is it to you? 
9. How do you think [If no to Q7: not] having a relationship impacts what is shared between 
you and community pharmacists? 
10. How willing are community pharmacists to share information in their conversations with 
your staff? 
a.  [PROBE] How open do you think your staff are in their conversations with 
community pharmacists? 
b.  [PROBE] What, if anything, would you like to be different? 
11. What kinds of things influence your willingness to work with community pharmacists? 
a.  [PROBE] How does your relationship with community pharmacists affect your 
desire to work with them?  
12. Do you think an established relationship leads to successful communication or does 




Appendices – cont. 
Qualitative Codebook 
Parent Code Child Code Definition 
Interaction Example  Code when participant describes an example of their 








Code when participant describes the type of 
information that community pharmacists share with 
PCPs  
PCP Information (shared) Code when participant describe the type of 
information that they usually share with community 
pharmacists 
PCP Information (not 
shared) 
Code when participant describes types of information 
they do not usually share with community pharmacists 
Process for receiving 
information 
Code when participant describes the PCP process for 
receiving information from community pharmacists 
Process for sharing 
information 
Code when participant describes the PCP process for 
sharing information with community pharmacists 
Information sharing 
recommendations 
Code when participant describes recommendations or 




Relationship Example Code when participant describes their relationship 
with community pharmacists 
PCP sentiment about 
relationships 
Code when participant describes how they feel about 
their relationship with community pharmacists 
Relationship impacts 
information sharing 
Code when participant describes how relationships 
impact sharing of information between community 
pharmacists and PCPs 
Community pharmacy 
practice willingness to 
communicate 
Code when participant describes their experience with 
community pharmacy practice willingness to 
communicate or share information with PCP 
 PCP practice willingness to 
communicate 
Code when participant describes their experience with 
PCP practice willingness to communicate or share 
information with community pharmacist 
Influencing factors Code when participant describes factors that influence 




Code when participant describes impact of 
relationship on communication or vice versa (which 
comes first?) 
Recommendations Code when participant describes any additional 
recommendations or thoughts related to these topics 
 
 
